VBCSS student intern Sophie Mulrow awarded
April 16, 2019
Sophie Mulrow has been a work-study student with the VBCSS for all four years of her undergraduate studies at UVM. Today she was awarded second place in the 2018-2019 UVM Student Employee of the Year competition. She was recognized for her valuable contributions to the development and testing of new patient matching programs that the VBCSS now uses to integrate data from multiple healthcare facilities across Vermont. Congratulations Sophie for being recognized out of over 3000 UVM student employees!
October 30, 2018
VBCSS Director Dr. Brian Sprague received the Mid-Career Investigator Award at the University of Vermont Larner College of Medicine's "Dean's Excellence in Research" event. The award recognized the impact of Dr. Sprague's epidemiologic research on our understanding of breast cancer risk and breast cancer screening. The event highlighted research
being conducted by faculty, postdoctoral trainees, and
graduate students within the college, with a Keynote Address given by Elaine Ostrander, Ph.D., of the National Institutes of Health.
June 15, 2018
VBCSS investigator and UVMMC Director of Breast Imaging Dr. Sally Herschorn provided insights on digital breast tomosynthesis and breast ultrasound to Consumer Reports for their report on "What kind of breast cancer screening should you get?". The report helps women make sense of the many options now available for breast cancer screening.
Department of Defense Patriot Award
April 4, 2018
The Office of Health Promotion Research received the Department of Defense Patriot Award to recognize its support of VBCSS staff member and Vermont Army Reserve National Guard combat medic Denis Nunez. VBCSS administrator Dawn Pelkey accepted the award on behalf of the department. The award recognizes employers for their outstanding support and flexibility in employing service members who are frequently called to duty on short notice for critical missions in Vermont and around the world. We thank Denis for his service to our country and his great work for the VBCSS!
VBCSS Awarded Grant to Study Digital Breast Tomosynthesis
December 15, 2017
The Vermont Breast Cancer Surveillance System has been awarded a grant from the National Cancer Institute to study a new technology in breast cancer screening. Digital breast tomosynthesis improves breast cancer screening performance when added to conventional 2D digital mammography, though there are concerns regarding the extra radiation dose. In a multi-center study, including a collaboration with the University of Pennsylvania, we will evaluate the clinical performance of a new approach in which digital breast tomosynthesis is used with synthetic 2D images instead of conventional 2D mammography.
October 20, 2017
Consumer Reports interviewed VBCSS investigators Dr. Brian Sprague and Dr. Sally Herschorn for a special report on what factors patients can consider when choosing a mammography facility for their breast cancer screening.
August 10, 2017
The Vermont Breast Cancer Surveillance System (VBCSS) will
receive $1.8 million over 5 years as part of a $17 million grant to
continue the work of the Breast Cancer Surveillance Consortium (BCSC). This program project grant renewal from the National Cancer Institute will support new investigation of different breast cancer screening and surveillance strategies using
digital mammography, digital breast tomosynthesis (three-dimensional
mammography), and breast magnetic resonance imaging (MRI).
May 16, 2017
The University of Vermont Department of Surgery held the 47th Annual Surgery Senior Major Scientific Program on May 4, 2017 to showcase the scholarly work of Larner College of Medicine students who will be specializing in surgery following graduation. Jacqueline Wade ’17 received the second-place prize for her project using VBCSS data,
titled “The Impact of Mammographic Screening on the Use of Chemotherapy
for Breast Cancer in Women Ages 40-49.”
February 28, 2017
The shift from film to digital technology for diagnostic mammography appears to have improved
cancer detection rates for diagnostic mammography, but also has
increased the abnormal interpretation rate, which may lead to more women
undergoing biopsies for benign conditions, according to a new study published in the journal Radiology.
November 1, 2016
Dr. Vicki Hart received a Dean's Excellence in Research Trainee Award for Outstanding Research Publication/Postdoctoral Fellows at the inaugural Larner College of Medicine's "Dean’s Excellence in Research Awards" event held on November 1, 2016. Dean Morin and Associate Dean for Research Jensen presented Dr. Hart with the award for her paper titled "Trends in health related quality of life following a diagnosis of ductal carcinoma in situ", which was published earlier this year in Journal of Clinical Oncology. Dr. Hart conducted the study as a postdoctoral researcher with the VBCSS.
August 22, 2016
One size doesn’t fit all women in clothing, and neither should all women
have mammograms on the same schedule, a new national study concludes. A large computer modeling study led by Dr. Amy Trentham-Dietz of the University of Wisconsin Carbone Cancer Center
found that the majority of women ages 50 to 74 can benefit if they have
mammograms every two or three years. These women at average risk can
retain most of the benefit of having mammograms less often and greatly
reduce the chances of false positive results and unneeded biopsies and
overdiagnosis, the study concludes.
July 22, 2016
In May, Vermont became the 28th state to adopt legislation
mandating reporting of breast density information to patients. New
University of Vermont (UVM) research - published July 18, 2016 in the
Annals of Internal Medicine - shows that density assessment, as
currently practiced, is subjective and highly variable across
radiologists and warns of the implications of relying on the subjective
measurement for clinical decision-making for breast cancer screening.
WCAX television segment
November 11, 2015
While better technology and screening practices have led to the
detection of more breast cancers in women—many of which fall into a
broad category of early-stage cancer, including ductal carcinoma in situ
or DCIS—researchers still do not understand why some of these early
cancers remain idle, while others progress. With the support of a new,
$3.7 million federal grant from the National Cancer Institute (NCI), an
interdisciplinary team of researchers at the University of Vermont (UVM)
Cancer Center will be looking to answer this question.
WCAX television segment
October 20, 2015
Premenopausal women, or women still experiencing menstruation, over age
40 may want annual mammograms to increase their chances of finding
cancers earlier, suggests a new study that found a screening mammogram
once every two years is safe for postmenopausal women at average risk of
breast cancer. The results are reported in the October 21, 2015 Online
First edition of Journal of the American Medical Association (JAMA) Oncology.
March 17, 2015
The accuracy of pathologists’ diagnoses is an important and
under-studied area. Now, a new study released this week in the March 17
issue of JAMA reports that pathologists interpreting breast
biopsies have high levels of agreement on the most serious of breast
cancers – invasive – and lower levels of agreement for biopsy
interpretations of ductal carcinoma in situ, commonly referred to as
DCIS, and atypical hyperplasia, also referred to as “atypia.”
WCAX television segment
December 8, 2014
A new study released in the Annals of Internal Medicine and led by Brian Sprague, Ph.D.,
at the University of Vermont Cancer Center concludes that supplemental
ultrasound screening for women with dense breasts would substantially
increase costs with little improvement in overall outcomes. The research
provides needed evidence on the benefits and harms of breast cancer
screening options for women with dense breasts, and informs the
discussion of national legislation that would mandate the disclosure of
breast density information to women.
WCAX television segment